Department Vision, Mission & Values
Vision: To be a leader in pharmacy and postgraduate education through excellence in translational, clinical and outcomes research
Mission: To advance health through innovation and excellence in pharmacy education, training, research, patient care and community service in diverse populations.
The College of Pharmacy's Department of Clinical Sciences and Administration is chaired by Professor Kevin W. Garey, Pharm.D., M.S., FASHP, with Clinical Associate Professor Lynn Simpson, Pharm.D., serving as Department Vice Chair.
Pharmacy Practice faculty members play a key role in the pharmaceutical care of patients in partnering institutions and the delivery of the professional curriculum. Division faculty members are innovative leaders in the development and expansion of pharmaceutical care services that serve health-care professionals, patients and the public at-large.
These faculty members provide both didactic (classroom, tutorial and laboratory) and experiential training to become leaders in today's dynamic healthcare environment. They also contribute to scholarly and other professional activities while participating in service commitments to the College of Pharmacy and their respective institutions.
The division includes 18 clinical track faculty members who provide pharmaceutical care and teaching at several sites in the Texas Medical Center and greater Houston area, including:
Harris Health System;
MD Anderson Cancer Center;
Houston Methodist Hospital;
Michael E. DeBakey Veterans Affairs Medical Center;
CHI St. Luke's Health System; and
The department's tenured or tenure-track faculty members provide clinical service and conduct nationally and internationally recognized translational research in the areas of critical care medicine, infectious diseases, oncology. The research group occupies approximately 4,000 square feet of laboratory space in the Texas Medical Center with core expertise in:
Pharmacokinetic/Pharmacodynamic (PK/PD) modeling;
Animal model of infection;
Molecular pathogen typing;
Patient genotyping; and
Population surveillance/outcome studies.